DOSAGE INDEX / SINGLE
Vilon
Research, reported schedules and supply planning.
Review Vilon tissue, spleen and mouse gene-expression research, with a transparent distinction between an indexed lifespan paper and fully appraised evidence.
Source: PeptideDosages.com. Independently written summaries of reported protocols, not validated treatment recommendations. Reviewed for transcription on September 21, 2026.
Research Protocol & Dosage
Source-reported examples · not treatment recommendations
- Amount
- 67–667 micrograms per administration across its examples
- Frequency
- Daily for five days per four-week cycle
- Cycle / observation period
- Two to four cycles
- Route / research model
- Subcutaneous
Titration & progression
A dose range is not a titration schedule. No independently verified stepwise escalation has been established for this source-reported regimen.
Supply & Planning
Compare vial strengths here. A different vial size changes the available material, not the biological dose.
Diluent & formulation
Diluent compatibility is formulation-specific. A verified manufacturer instruction is still needed before bacteriostatic water or another diluent can be listed as suitable for this research material.
Vial comparison
No single complete schedule is resolved for this entry. Enter a documented total to compare strengths; the calculator does not select a regimen.
| Vial strength | Vials needed |
|---|---|
| 20 mg | Enter a total |
Enter a positive material total.
Material minimum only: round total material ÷ vial content up to a whole vial. Actual supply may be higher because of single-use packaging, discard dates, dead space or losses. No validated multi-use storage period is assumed.
Reported Research Results
Selected observations from the cited research. Each finding retains its study population, formulation and limitations.
- A 2001 study reported Vilon-associated growth of rat thymus explants in culture. The experiment did not measure infection resistance or lifespan. [1]
- A 2014 comparative report linked Vilon with T-helper activity and decreased apoptosis in the aging spleen. It assigned different responses to other peptides, including a negative cell-renewal finding for Crystagen. Each result should remain attached to its preparation. [2]
- A 2002 study examined cardiac gene-expression patterns in mice receiving Vilon, Epithalon or their combination. The reported patterns differed among interventions. These were transcript measurements in mouse heart tissue, not a clinical demonstration of improved immunity, cardiac performance or lifespan. [3]
Sourcing & Vendor Information
No compound-specific affiliate destination is listed here yet. Browse the Vendors Index for the available supplier records and disclosed relationships.
Sources & Further Reading
Medical publications and supporting literature from the corresponding protocol bibliographies, combined across vial strengths. Supplier and commercial catalog references are excluded. Duplicate destinations appear once. Inclusion does not mean that a paper validates the reported dose, or that an ingredient study tests the finished blend.
Bibliography checked September 22, 2026: 12 entries mapped from 1 source page. Medical and supporting references are retained below; supplier entries are excluded.
- Original tissue study
- Original comparison
- Original microarray study
- Sevostianova NN et al. (2013)Further reading · Listed in reference bibliography.
- Kazakova TB et al. (2002)Further reading · Listed in reference bibliography.
- Gavrisheva NA et al. (2005)Further reading · Listed in reference bibliography.
- Kniaz’kin IA et al. (2002)Further reading · Listed in reference bibliography.
- Araj SK et al. (2025)Further reading · Listed in reference bibliography.
- Chernyak EY et al. (2000)Further reading · Listed in reference bibliography.
- Avolio F et al. (2022)Further reading · Listed in reference bibliography.
- Wong AKC et al. (2024)Further reading · Listed in reference bibliography.
- MedlinePlus (NIH)General guidance · Listed in reference bibliography.
- CDCGeneral guidance · Listed in reference bibliography.
- NCBI BookshelfFurther reading · Listed in reference bibliography.
Reported schedule reference: PeptideDosages.com. Research findings are summarized independently from the listed sources.